Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05053152
Title Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer (NRG PROMETHEAN)
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors NRG Oncology
Indications

prostate adenocarcinoma

Therapies

Relugolix

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.